jueves, 17 de enero de 2019

Phase 2 CF Trial Testing SPI-1005 for Ototoxicity Moving Forward

Phase 2 CF Trial Testing SPI-1005 for Ototoxicity Moving Forward

Cystic Fibrosis News Today

Phase 2 Trial Testing SPI-1005 for Ototoxicity in CF Patients Moving Forward

No hay comentarios:

Publicar un comentario